Cargando…

Tecovirimat for the treatment of severe Mpox in Germany

BACKGROUND: In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in Orthopox viruses inhibits the function of a major envelope protein required f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermanussen, Lennart, Brehm, Thomas Theo, Wolf, Timo, Boesecke, Christoph, Schlabe, Stefan, Borgans, Frauke, Monin, Malte B., Jensen, Björn-Erik Ole, Windhaber, Stefan, Scholten, Stefan, Jordan, Sabine, Lütgehetmann, Marc, Wiesch, Julian Schulze zur, Addo, Marylyn M., Mikolajewska, Agata, Niebank, Michaela, Schmiedel, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240449/ https://www.ncbi.nlm.nih.gov/pubmed/37273167 http://dx.doi.org/10.1007/s15010-023-02049-0

Ejemplares similares

Disseminated tuberculosis during TNF-α inhibitor therapy diagnosed by positron emission tomography and mini-laparoscopy
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Orthopox simiae muscle abscess
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022)

High‐resolution analysis of individual spike peptide‐specific CD4 (+) T‐cell responses in vaccine recipients and COVID‐19 patients
por: Karsten, Hendrik, et al.
Publicado: (2022)

Severe monkeypox-virus infection in undiagnosed advanced HIV infection
por: Boesecke, Christoph, et al.
Publicado: (2022)

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
por: Smith, Todd G., et al.
Publicado: (2023)

Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
por: Cords, Leon, et al.
Publicado: (2023)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness
por: Jochum, Johannes, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.
por: Nörz, Dominik, et al.
Publicado: (2022)

Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022
por: Nörz, Dominik, et al.
Publicado: (2022)

2684. Characteristics of mpox patients treated with Tecovirimat: a single center review
por: Vargas, Robert, et al.
Publicado: (2023)

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
por: Kraef, Christian, et al.
Publicado: (2019)

1790. Characteristics of Patients with Mpox Treated with Tecovirimat during the 2022 Outbreak in Puerto Rico
por: Gonzalez, Hector J Melendez, et al.
Publicado: (2023)

Respiratory muscle dysfunction in long-COVID patients
por: Hennigs, Jan K., et al.
Publicado: (2022)

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
por: Heyer, Andreas, et al.
Publicado: (2022)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

Impact of COVID‐19 on HIV late diagnosis in a specialized German centre
por: van Bremen, Kathrin, et al.
Publicado: (2022)

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Frequent neurocognitive deficits after recovery from mild COVID-19
por: Woo, Marcel S, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System
por: Vo, Christopher, et al.
Publicado: (2023)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
por: Lash, Maura K., et al.
Publicado: (2023)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022
por: Ettemeyer, Marlene, et al.
Publicado: (2023)

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4(+) T-cell response with pre-primed responses directed against common cold coronaviruses
por: Westphal, Tim, et al.
Publicado: (2023)

Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
por: Woo, Marcel S., et al.
Publicado: (2021)

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19
por: Wildner, Nils H, et al.
Publicado: (2020)

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
por: Boesecke, Christoph, et al.
Publicado: (2017)

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Mpox, een seksueel overdraagbare virale zoönose
por: Posthuma, Jean-Paul, et al.
Publicado: (2023)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl4776hi1aeg312vhgbu7ine30